Table 3.
Recurrent molecular abnormalities in adult CN-AML: incidence, prognostic and/or predictive significance, and potential as druggable targets
*Conversely, in one study, IDH1 and/or IDH2 mutations represent favorable factors for OS in intermediate-risk AML.11
†Adverse impact on OS reported also in intermediate-risk AML.37,39
‡Study not limited to CN-AML.40
§Reviewed in Wander et al.82
